The regulation of AβPP expression by RNA-binding proteins

Ageing Research Reviews

Volumn 11, Issue 4, 2012, Pages 450-459

  Westmark, Cara J ^a   Malter, James S ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

A ; A PP; FMRP; HnRNP C; Nucleolin; Post transcriptional gene regulation

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; GAMMA SECRETASE; MESSENGER RNA; RNA BINDING PROTEIN;

ALZHEIMER DISEASE; DOWN SYNDROME; HUMAN; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; REVIEW; SENILE PLAQUE;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84866518539     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.03.005     Document Type: Review

References (121)

1. Akaaboune M., Allinquant B., Farza H., Roy K., Magoul R., Fiszman M., Festoff B.W., Hantai D. Developmental regulation of amyloid precursor protein at the neuromuscular junction in mouse skeletal muscle. Molecular and Cellular Neuroscience 2000, 15:355-367.
2. Akao Y., Marukawa O., Morikawa H., Nakao K., Kamei M., Hachiya T., Tsujimoto Y. The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Research 1995, 55:3444-3449.
3. Amara F.M., Junaid A., Clough R.R., Liang B. TGF-beta(1), regulation of Alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization. Brain Research Molecular Brain Research 1999, 71:42-49.
4. Ansari S.A., Safak M., Gallia G.L., Sawaya B.E., Amini S., Khalili K. Interaction of YB1 with human immunodeficiency virus type 1 tat and TAR RNA modulates viral promoter activity. Journal of General Virology 1999, 80:2629-2638.
5. Bagni C., Greenough W.T. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nature Reviews Neuroscience 2005, 6:376-387.
6. Balagopal V., Parker R. Polysomes, P bodies and stress granules: states and fates of eukaryotic mRNAs. Current Opinion in Cell Biology 2009, 21:403-408.
7. Bandyopadhyay S., Huang X., Lahiri D.K., Rogers J.T. Novel drug targets based on metallobiology of Alzheimer's disease. Expert Opinion on Therapeutic Targets 2010, 14:1177-1197.
8. Barbee S.A., Estes P.S., Cziko A.M., Hillebrand J., Luedeman R.A., Coller J.M., Johnson N., Howlett I.C., Geng C., Ueda R., Brand A.H., Newbury S.F., Wilhelm J.E., Levine R.B., Nakamura A., Parker R., Ramaswami M. Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies. Neuron 2006, 52:997-1009.
9. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., Yednock T. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Medicine 2000, 6:916-919.
10. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends in Neurosciences 2004, 27:370-377.
11. Belenguer P., Baldin V., Mathieu C., Prats H., Bensaid M., Bouche G., Amalric F. Protein kinase NII and the regulation of rDNA transcription in mammalian cells. Nucleic Acids Research 1989, 17:6625-6636.
12. Borer R.A., Lehner C.F., Eppenberger H.M., Nigg E.A. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989, 56:379-390.
13. Bouvet P., Diaz J.J., Kindbeiter K., Madjar J.J., Amalric F. Nucleolin interacts with several ribosomal proteins through its RGG domain. Journal of Biological Chemistry 1998, 273:19025-19029.
14. Bouvet P., Matsumoto K., Wolffe A.P. Sequence-specific RNA recognition by the Xenopus Y-box proteins. An essential role for the cold shock domain. Journal of Biological Chemistry 1995, 270:28297-28303.
15. Brewer G. An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Molecular and Cellular Biology 1991, 11:2460-2466.
16. Brockstedt E., Rickers A., Kostka S., Laubersheimer A., Dorken B., Wittmann-Liebold B., Bommert K., Otto A. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3. Journal of Biological Chemistry 1998, 273:28057-28064.
17. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D., Darnell R.B., Warren S.T. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 2001, 107:477-487.
18. Broytman O., Westmark P.R., Gurel Z., Malter J.S. Rck/p54 interacts with APP mRNA as part of a multi-protein complex and enhances APP mRNA and protein expression in neuronal cell lines. Neurobiology of Aging 2008, 30:1962-1974.
19. Broytman O., Malter J.S. Anti-abeta: the good, the bad, and the unforeseen. Journal of Neuroscience Research 2004, 75:301-306.
20. Capowski E.E., Esnault S., Bhattacharya S., Malter J.S. Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. Journal of Immunology 2001, 167:5970-5976.
21. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., Cerami A. Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proceedings of the National Academy of Sciences of the United States of America 1986, 83:1670-1674.
22. Ceman S., Brown V., Warren S.T. Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Molecular and Cellular Biology 1999, 19:7925-7932.
23. Check E. Nerve inflammation halts trial for Alzheimer's drug. Nature 2002, 415:462.
24. Chen C.Y., Gherzi R., Andersen J.S., Gaietta G., Jurchott K., Royer H.D., Mann M., Karin M. Nucleolin and YB1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes & Development 2000, 14:1236-1248.
25. Chen L., Yun S.W., Seto J., Liu W., Toth M. The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences. Neuroscience 2003, 120:1005-1017.
26. Cho H.H., Cahill C.M., Vanderburg C.R., Scherzer C.R., Wang B., Huang X., Rogers J.T. Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. Journal of Biological Chemistry 2010, 285:31217-31232.
27. Choi Y.D., Grabowski P.J., Sharp P.A., Dreyfuss G. Heterogeneous nuclear ribonucleoproteins: role in RNA splicing. Science 1986, 231:1534-1539.
28. Choi Y.D., Dreyfuss G. Isolation of the heterogeneous nuclear RNA-ribonucleoprotein complex (hnRNP): a unique supramolecular assembly. Proceedings of the National Academy of Sciences of the United States of America 1984, 81:7471-7475.
29. Chu C.Y., Rana T.M. Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biology 2006, 4:e210.
30. Clarke S.L., Vasanthakumar A., Anderson S.A., Pondarre C., Koh C.M., Deck K.M., Pitula J.S., Epstein C.J., Fleming M.D., Eisenstein R.S. Iron-responsive degradation of iron-regulatory protein 1 does not require the Fe-S cluster. EMBO Journal 2006, 25:544-553.
31. Coller J.M., Tucker M., Sheth U., Valencia-Sanchez M.A., Parker R. The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA 2001, 7:1717-1727.
32. Cox T.C., Bawden M.J., Martin A., May B.K. Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO Journal 1991, 10:1891-1902.
33. Darnell J.C., Fraser C.E., Mostovetsky O., Stefani G., Jones T.A., Eddy S.R., Darnell R.B. Kissing complex RNAs mediate interaction between the fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes & Development 2005, 19:903-918.
34. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 2001, 107:489-499.
35. de Sauvage F., Kruys V., Marinx O., Huez G., Octave J.N. Alternative polyadenylation of the amyloid protein precursor mRNA regulates translation. EMBO Journal 1992, 11:3099-3103.
36. Denman R., Potempska A., Wolfe G., Ramakrishna N., Miller D.L. Distribution and activity of alternatively spliced Alzheimer amyloid peptide precursor and scrapie PrP mRNAs on rat brain polysomes. Archives of Biochemistry and Biophysics 1991, 288:29-38.
37. Derenzini M., Sirri V., Trere D., Ochs R.L. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Laboratory Investigation 1995, 73:497-502.
38. Didier D.K., Schiffenbauer J., Woulfe S.L., Zacheis M., Schwartz B.D. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proceedings of the National Academy of Sciences of the United States of America 1988, 85:7322-7326.
39. Dolzhanskaya N., Sung Y.J., Conti J., Currie J.R., Denman R.B. The fragile X mental retardation protein interacts with U-rich RNAs in a yeast three-hybrid system. Biochemical and Biophysical Research Communications 2003, 305:434-441.
40. Egyhazi E., Pigon A., Chang J.H., Ghaffari S.H., Dreesen T.D., Wellman S.E., Case S.T., Olson M.O. Effects of anti-C23 (nucleolin) antibody on transcription of ribosomal DNA in chironomus salivary gland cells. Experimental Cell Research 1988, 178:264-272.
41. Erard M.S., Belenguer P., Caizergues-Ferrer M., Pantaloni A., Amalric F. A major nucleolar protein, nucleolin, induces chromatin decondensation by binding to histone H1. European Journal of Biochemistry 1988, 175:525-530.
42. Eulalio A., Behm-Ansmant I., Izaurralde E. P bodies: at the crossroads of post-transcriptional pathways. Nature Reviews Molecular Cell Biology 2007, 8:9-22.
43. Fahling M., Steege A., Perlewitz A., Nafz B., Mrowka R., Persson P.B., Thiele B.J. Role of nucleolin in posttranscriptional control of MMP-9 expression. Biochimica et Biophysica Acta 2005, 1731:32-40.
44. Ford L.P., Suh J.M., Wright W.E., Shay J.W. Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase. Molecular and Cellular Biology 2000, 20:9084-9091.
45. Friedmann C., Davis L., Ciccone P., Rubin R. Phase II double blind controlled study of a new anxiolytic, fenobam (McN-3377) vs placebo. Current Therapeutic Research 1980, 274:144-151.
46. Gillis P., Malter J.S. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs. Journal of Biological Chemistry 1991, 266:3172-3177.
47. Ginisty H., Amalric F., Bouvet P. Nucleolin functions in the first step of ribosomal RNA processing. EMBO Journal 1998, 17:1476-1486.
48. Hamilton B.J., Nagy E., Malter J.S., Arrick B.A., Rigby W.F. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. Journal of Biological Chemistry 1993, 268:8881-8887.
49. Heaton J.H., Dlakic W.M., Gelehrter T.D. Posttranscriptional regulation of PAI-1 gene expression. Thrombosis and Haemostasis 2003, 89:959-966.
50. Heaton J.H., Dlakic W.M., Dlakic M., Gelehrter T.D. Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the type-1 plasminogen activator inhibitor mRNA. Journal of Biological Chemistry 2001, 276:3341-3347.
51. Holcik M., Gordon B.W., Korneluk R.G. The internal ribosome entry site-mediated translation of antiapoptotic protein XIAP is modulated by the heterogeneous nuclear ribonucleoproteins C1 and C2. Molecular and Cellular Biology 2003, 23:280-288.
52. Huang L., Fu H., Lin C.M., Conner A.L., Zhang Y., Aladjem M.I. Prevention of transcriptional silencing by a replicator-binding complex consisting of SWI/SNF, MeCP1, and hnRNP C1/C2. Molecular and Cellular Biology 2011, 31:3472-3484.
53. Huber K.M., Gallagher S.M., Warren S.T., Bear M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:7746-7750.
54. Inamura N., Hoshino S., Uchiumi T., Nawa H., Takei N. Cellular and subcellular distributions of translation initiation, elongation and release factors in rat hippocampus. Brain Research Molecular Brain Research 2003, 111:165-174.
55. Irwin S.A., Galvez R., Greenough W.T. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cerebral Cortex 2000, 10:1038-1044.
56. Jordan G. At the heart of the nucleolus. Nature 1987, 329:489-490.
57. Khacho M., Mekhail K., Pilon-Larose K., Pause A., Cote J., Lee S. eEF1A is a novel component of the mammalian nuclear protein export machinery. Molecular Biology of the Cell 2008, 19:5296-5308.
58. Kibbey M.C., Johnson B., Petryshyn R., Jucker M., Kleinman H.K. A 110-kD nuclear shuttling protein, nucleolin, binds to the neurite-promoting IKVAV site of laminin-1. Journal of Neuroscience Research 1995, 42:314-322.
59. Kim H.Y., Klausner R.D., Rouault T.A. Translational repressor activity is equivalent and is quantitatively predicted by in vitro RNA binding for two iron-responsive element-binding proteins, IRP1 and IRP2. Journal of Biological Chemistry 1995, 270:4983-4986.
60. Kotilinek L.A., Bacskai B., Westerman M., Kawarabayashi T., Younkin L., Hyman B.T., Younkin S., Ashe K.H. Reversible memory loss in a mouse transgenic model of Alzheimer's disease. Journal of Neuroscience 2002, 22:6331-6335.
61. Laggerbauer B., Ostareck D., Keidel E.M., Ostareck-Lederer A., Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Human Molecular Genetics 2001, 10:329-338.
62. Lagnado C.A., Brown C.Y., Goodall G.J. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Molecular and Cellular Biology 1994, 14:7984-7995.
63. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Phillips R.S., Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Molecular and Cellular Biology 1999, 19:4311-4323.
64. Lapierre Y., Oyewumi L. Fenobam: another anxiolytic?. Current Therapeutic Research 1982, 31:95-101.
65. Lee E.K., Kim H.H., Kuwano Y., Abdelmohsen K., Srikantan S., Subaran S.S., Gleichmann M., Mughal M.R., Martindale J.L., Yang X., Worley P.F., Mattson M.P., Gorospe M. hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies. Nature Structural & Molecular Biology 2010, 17:732-739.
66. Li Z., Zhang Y., Ku L., Wilkinson K.D., Warren S.T., Feng Y. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Research 2001, 29:2276-2283.
67. Long J.M., Lahiri D.K. MicroRNA-101 downregulates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed. Biochemical and Biophysical Research Communications 2011, 404:889-895.
68. Mahajan M.C., Narlikar G.J., Boyapaty G., Kingston R.E., Weissman S.M. Heterogeneous nuclear ribonucleoprotein C1/C2, MeCP1, and SWI/SNF form a chromatin remodeling complex at the beta-globin locus control region. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:15012-15017.
69. Malter J.S., Ray B.C., Westmark P.R., Westmark C.J. Fragile X syndrome and Alzheimer's disease: another story about APP and beta-amyloid. Current Alzheimer Research 2010, 7:200-206.
70. Malter J.S. Identification of an AUUUA-specific messenger RNA binding protein. Science 1989, 246:664-666.
71. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:4245-4249.
72. Mazroui R., Huot M.E., Tremblay S., Filion C., Labelle Y., Khandjian E.W. Trapping of messenger RNA by fragile X mental retardation protein into cytoplasmic granules induces translation repression. Human Molecular Genetics 2002, 11:3007-3017.
73. McLaren R.S., Caruccio N., Ross J. Human La protein: a stabilizer of histone mRNA. Molecular and Cellular Biology 1997, 17:3028-3036.
74. Millard S.S., Vidal A., Markus M., Koff A. A U-rich element in the 5'-untranslated region is necessary for the translation of p27 mRNA. Molecular and Cellular Biology 2000, 20:5947-5959.
75. Minshall N., Kress M., Weil D., Standart N. Role of p54 RNA helicase activity and its C-terminal domain in translational repression, P-body localization and assembly. Molecular Biology of the Cell 2009, 20:2464-2472.
76. Minshall N., Reiter M.H., Weil D., Standart N. CPEB interacts with an ovary-specific eIF4E and 4E-T in early Xenopus oocytes. Journal of Biological Chemistry 2007, 282:37389-37401.
77. Miyashiro K.Y., Beckel-Mitchener A., Purk T.P., Becker K.G., Barret T., Liu L., Carbonetto S., Weiler I.J., Greenough W.T., Eberwine J. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 2003, 37:417-431.
78. Morgan D. Mechanisms of A-beta plaque clearance following passive A-beta immunization. Neurodegenerative Diseases 2005, 2:261-266.
79. Panza F., Frisardi V., Solfrizzi V., Imbimbo B.P., Logroscino G., Santamato A., Greco A., Seripa D., Pilotto A. Interacting with gamma-secretase for treating Alzheimer's disease: from inhibition to modulation. Current Medicinal Chemistry 2011, 18:5430-5447.
80. Parker R., Sheth U. P bodies and the control of mRNA translation and degradation. Molecular Cell 2007, 25:635-646.
81. Patel N., Hoang D., Miller N., Ansaloni S., Huang Q., Rogers J.T., Lee J.C., Saunders A.J. MicroRNAs can regulate human APP levels. Molecular Neurodegeneration 2008, 3:10.
82. Pecknold J., McClure D., Appeltauer L. Fenobam in anxious outpatients. Current Therapeutic Research 1980, 274:119-123.
83. Pecknold J.C., McClure D.J., Appeltauer L., Wrzesinski L., Allan T. Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study. Journal of Clinical Psychopharmacology 1982, 2:129-133.
84. Pfeifer M., Boncristiano S., Bondolfi L., Stalder A., Deller T., Staufenbiel M., Mathews P.M., Jucker M. Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 2002, 298:1379.
85. Racke M.M., Boone L.I., Hepburn D.L., Parsadainian M., Bryan M.T., Ness D.K., Piroozi K.S., Jordan W.H., Brown D.D., Hoffman W.P., Holtzman D.M., Bales K.R., Gitter B.D., May P.C., Paul S.M., DeMattos R.B. Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta. Journal of Neuroscience 2005, 25:629-636.
86. Rajagopalan L.E., Malter J.S. Growth factor-mediated stabilization of amyloid precursor protein mRNA is mediated by a conserved 29-nucleotide sequence in the 3'-untranslated region. Journal of Neurochemistry 2000, 74:52-59.
87. Rajagopalan L.E., Westmark C.J., Jarzembowski J.A., Malter J.S. hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA. Nucleic Acids Research 1998, 26:3418-3423.
88. Ranjan M., Tafuri S.R., Wolffe A.P. Masking mRNA from translation in somatic cells. Genes & Development 1993, 7:1725-1736.
89. Rockenstein E.M., McConlogue L., Tan H., Power M., Masliah E., Mucke L. Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. Journal of Biological Chemistry 1995, 270:28257-28267.
90. Rogers J.T., Randall J.D., Cahill C.M., Eder P.S., Huang X., Gunshin H., Leiter L., McPhee J., Sarang S.S., Utsuki T., Greig N.H., Lahiri D.K., Tanzi R.E., Bush A.I., Giordano T., Gullans S.R. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. Journal of Biological Chemistry 2002, 277:45518-45528.
91. Rogers J.T., Leiter L.M., McPhee J., Cahill C.M., Zhan S.S., Potter H., Nilsson L.N. Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5'-untranslated region sequences. Journal of Biological Chemistry 1999, 274:6421-6431.
92. Ruberti F., Barbato C., Cogoni C. Post-transcriptional regulation of amyloid precursor protein by microRNAs and RNA binding proteins. Communicative & Integrative Biology 2010, 3:499-503.
93. Santoro M.R., Bray S.M., Warren S.T. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Annual Review of Pathology 2012, 7:219-245.
94. Sengupta T.K., Bandyopadhyay S., Fernandes D.J., Spicer E.K. Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. Journal of Biological Chemistry 2004, 279:10855-10863.
95. Shaw G., Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46:659-667.
96. Shigematsu K., McGeer P.L., McGeer E.G. Localization of amyloid precursor protein in selective postsynaptic densities of rat cortical neurons. Brain Research 1992, 592:353-357.
97. Singh K., Laughlin J., Kosinski P.A., Covey L.R. Nucleolin is a second component of the CD154 mRNA stability complex that regulates mRNA turnover in activated T cells. Journal of Immunology 2004, 173:976-985.
98. Soba P., Eggert S., Wagner K., Zentgraf H., Siehl K., Kreger S., Lower A., Langer A., Merdes G., Paro R., Masters C.L., Muller U., Kins S., Beyreuther K. Homo- and heterodimerization of APP family members promotes intercellular adhesion. EMBO Journal 2005, 24:3624-3634.
99. Stefani G., Fraser C.E., Darnell J.C., Darnell R.B. Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. Journal of Neuroscience 2004, 24:7272-7276.
100. Stenina O.I., Poptic E.J., DiCorleto P.E. Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells. Journal of Clinical Investigation 2000, 106:579-587.
101. Tanner N.K., Linder P. DExD/H box RNA helicases: from generic motors to specific dissociation functions. Molecular Cell 2001, 8:251-262.
102. Thomson A.M., Rogers J.T., Leedman P.J. Thyrotropin-releasing hormone and epidermal growth factor regulate iron-regulatory protein binding in pituitary cells via protein kinase C-dependent and -independent signaling pathways. Journal of Biological Chemistry 2000, 275:31609-31615.
103. Tiedge H., Brosius J. Translational machinery in dendrites of hippocampal neurons in culture. Journal of Neuroscience 1996, 16:7171-7181.
104. Torroja L., Packard M., Gorczyca M., White K., Budnik V. The drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. Journal of Neuroscience 1999, 19:7793-7803.
105. Tuteja N., Huang N.W., Skopac D., Tuteja R., Hrvatic S., Zhang J., Pongor S., Joseph G., Faucher C., Amalric F. Human DNA helicase IV is nucleolin, an RNA helicase modulated by phosphorylation. Gene 1995, 160:143-148.
106. Wang X.Y., Hoyle P.E., McCubrey J.A. Characterization of proteins binding the 3' regulatory region of the IL-3 gene in IL-3-dependent and autocrine-transformed hematopoietic cells. Leukemia 1998, 12:520-531.
107. Westmark C.J., Westmark P.R., O'Riordan K.J., Ray B.C., Hervey C.M., Salamat M.S., Abozeid S.H., Stein K.M., Stodola L.A., Tranfaglia M., Burger C., Berry-Kravis E.M., Malter J.S. Reversal of fragile X phenotypes by manipulation of APP/Abeta levels in Fmr1 mice. PLoS ONE 2011, 6:e26549.
108. Westmark C.J., Malter J.S. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biology 2007, 5:e52.
109. Westmark C.J., Malter J.S. Extracellular-regulated kinase controls beta-amyloid precursor protein mRNA decay. Brain Research Molecular Brain Research 2001, 90:193-201.
110. Westmark C.J., Malter J.S. Up-regulation of nucleolin mRNA and protein in peripheral blood mononuclear cells by extracellular-regulated kinase. Journal of Biological Chemistry 2001, 276:1119-1126.
111. Westmark P.R., Shin H.C., Westmark C.J., Soltaninassab S.R., Reinke E.K., Malter J.S. Decoy mRNAs reduce beta-amyloid precursor protein mRNA in neuronal cells. Neurobiology of Aging 2006, 27:787-796.
112. Weston A., Sommerville J. Xp54 and related (DDX6-like) RNA helicases: roles in messenger RNP assembly, translation regulation and RNA degradation. Nucleic Acids Research 2006, 34:3082-3094.
113. Wilusz J., Shenk T. A uridylate tract mediates efficient heterogeneous nuclear ribonucleoprotein C protein-RNA cross-linking and functionally substitutes for the downstream element of the polyadenylation signal. Molecular and Cellular Biology 1990, 10:6397-6407.
114. Yang G., Gong Y.D., Gong K., Jiang W.L., Kwon E., Wang P., Zheng H., Zhang X.F., Gan W.B., Zhao N.M. Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2. Neuroscience Letters 2005, 384:66-71.
115. Yang T.H., Tsai W.H., Lee Y.M., Lei H.Y., Lai M.Y., Chen D.S., Yeh N.H., Lee S.C. Purification and characterization of nucleolin and its identification as a transcription repressor. Molecular and Cellular Biology 1994, 14:6068-6074.
116. Yurkova M.S., Murray M.T. A translation regulatory particle containing the Xenopus oocyte Y box protein mRNP3+4. Journal of Biological Chemistry 1997, 272:10870-10876.
117. Zaidi S.H., Malter J.S. Nucleolin and heterogeneous nuclear ribonucleoprotein C proteins specifically interact with the 3'-untranslated region of amyloid protein precursor mRNA. Journal of Biological Chemistry 1995, 270:17292-17298.
118. Zaidi S.H., Denman R., Malter J.S. Multiple proteins interact at a unique cis-element in the 3'-untranslated region of amyloid precursor protein mRNA. Journal of Biological Chemistry 1994, 269:24000-24006.
119. Zaidi S.H., Malter J.S. Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3'-untranslated region. Journal of Biological Chemistry 1994, 269:24007-24013.
120. Zalfa F., Giorgi M., Primerano B., Moro A., Di Penta A., Reis S., Oostra B., Bagni C. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 2003, 112:317-327.
121. Zubiaga A.M., Belasco J.G., Greenberg M.E. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Molecular and Cellular Biology 1995, 15:2219-2230.